Overview
Antifungal therapy is the use of agents that kill fungi or inhibit their growth to treat infections caused by yeasts, molds, and dimorphic fungi. Such infections range from superficial disease of the skin, nails, and mucous membranes to invasive and life-threatening conditions affecting the lungs, bloodstream, brain, and other organs, particularly in immunocompromised hosts. Antifungal drugs are grouped by mechanism, including agents that target ergosterol or its biosynthesis in the fungal membrane, those that inhibit synthesis of the cell-wall polysaccharide beta-glucan, and those that interfere with fungal nucleic acid synthesis; naturally derived compounds with antifungal activity are also investigated. Effective treatment depends on accurate identification of the organism, assessment of antifungal susceptibility, the site and severity of infection, and host factors, while the narrow selective targets of fungal cells, drug toxicity, and emerging resistance pose ongoing challenges. The scholarship gathered here reflects these themes, including the surge of mucormycosis in post-viral patients and its contributing factors, phytochemical activity against a Mucorales mold, diagnostic correlates in cryptococcal meningitis, surgical management of invasive aspergillosis, susceptibility of dermatophytes, and fungemia caused by an uncommon yeast. Together these studies illustrate how identification, susceptibility, and clinical context guide antifungal therapy across superficial and invasive fungal disease in diverse patient populations.
Research published in this journal
6 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Efficacy of Phytochemical Constituents of Castor Essential oil Towards the Mucor-Mycotic Mold Cunninghamella Bertholletiae
Correlation of Cryptococcal Antigen Assay with C-reactive Protein as Serum and Urine Biomarker in Cryptococcal Meningitis: Experience in a Tertiary Hospital
Surgical Managment of Intracranial Invasive Aspergillosis in Immunocompetent Patients: Results from 3 Case Reports
Saccharomyces Kluyveri Fungemia in a Patient with Human Immunodeficiency Virus Infection
How this research is being cited
The 6 articles above have been cited 28 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Journal of the Indian Chemical Society
-
2026 · Cereal Research Communications
-
2026 · South African Journal of Botany
-
2024 · Expert Review of Molecular Diagnostics
-
2024 · ACS Omega
-
2024 · Frontiers in Microbiology
-
2024 · European Journal of Medical Research
-
2024 · Brazilian Journal of Microbiology
A sample of recent works citing this journal's research on Antifungal Therapy, linking to each citing work.